Literature DB >> 19268443

Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis.

Francesco Mariani1, Paola Sena, Laura Marzona, Massimo Riccio, Rita Fano, Paola Manni, Carmela Di Gregorio, Annalisa Pezzi, Maurizio Ponz de Leon, Sebastiano Monni, Anto De Pol, Luca Roncucci.   

Abstract

Chronic mucosal inflammation is considered a risk factor for colorectal cancer. Neutrophils are a major source of oxidants, whereas cyclooxygenase 2 (COX-2) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) protein expression levels are increased in inflammatory and malignant lesions. The main purpose of the present study was to evaluate myeloperoxidase (MPO) positive cell infiltration, COX-2 and HIF-1alpha protein expression in colorectal carcinogenesis, especially in its early phases, using immunohistochemistry and immunofluorescence confocal microscopy techniques. MPO, COX-2 and HIF-1alpha proteins were expressed at higher rates in the normal colorectal mucosa of patients with inflammatory bowel diseases and colorectal tumours than in patients with normal colonoscopy. A gradual increase in COX-2 and HIF-1alpha protein expression was observed in dysplastic aberrant crypt foci, adenomas and carcinomas, showing a strong relation to dysplasia. In conclusion, the present study supports the hypothesis of a key role of inflammation in malignant transformation of colorectal mucosa. The evaluation of some early markers related to inflammation in the mucosa of the large bowel may serve as potential tool for prognosis and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268443     DOI: 10.1016/j.canlet.2009.02.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  38 in total

Review 1.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

2.  Metabolic regulation of intestinal epithelial barrier during inflammation.

Authors:  Sean P Colgan; Valerie F Curtis; Jordi M Lanis; Louise E Glover
Journal:  Tissue Barriers       Date:  2015-04-03

3.  Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.

Authors:  Martha L Slattery; Abbie Lundgreen; Bill Welbourn; Roger K Wolff; Christopher Corcoran
Journal:  Mutat Res       Date:  2012-04-15       Impact factor: 2.433

Review 4.  Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa.

Authors:  Eric L Campbell; Sean P Colgan
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

Review 5.  Neutrophils and inflammatory resolution in the mucosa.

Authors:  Sean P Colgan
Journal:  Semin Immunol       Date:  2015-03-26       Impact factor: 11.130

6.  Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring.

Authors:  Emily S Jungheim; Erica L Schoeller; Kerri L Marquard; Erica D Louden; Jean E Schaffer; Kelle H Moley
Journal:  Endocrinology       Date:  2010-06-23       Impact factor: 4.736

Review 7.  Hypoxia: an alarm signal during intestinal inflammation.

Authors:  Sean P Colgan; Cormac T Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 8.  Hypoxia and Mucosal Inflammation.

Authors:  Sean P Colgan; Eric L Campbell; Douglas J Kominsky
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

9.  The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.

Authors:  Hilbert S de Vries; Rene H M te Morsche; Martijn G H van Oijen; Iris D Nagtegaal; Wilbert H M Peters; Dirk J de Jong
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

Review 10.  The inflammatory tissue microenvironment in IBD.

Authors:  Sean P Colgan; Valerie F Curtis; Eric L Campbell
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.